Related Experiment Video
Updated: Aug 5, 2026

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
Apoptosis and muscle fibre loss in neuromuscular disorders
1Neurologisches Edinger-Institut, Johann-Wolfgang Goethe-University Medical Center, Deutschordenstrasse 46, D-60528, Frankfurt, Germany.
Abstract:
The past decade has witnessed increasing evidence that besides necrosis, apoptotic cell death mechanisms contribute to muscle fibre loss in various neuromuscular conditions, including the muscular dystrophies, metabolic myopathies, and cases of denervation. The up-regulation of bax and bcl-2, both members of the bcl-2 family, indicate that the predominant effectors involve permeability transition pores in the mitochondrial membrane and subsequent caspase activation which confers the typical morphological and biochemical features of apoptosis such as DNA-fragmentation. It is likely that apoptotic degradation of nuclei and contractile elements is a localized event in muscle fibre segments leading to muscle fibre atrophy and finally loss in these disorders. Essential triggers of apoptosis seem to be homeostatic dysregulation as well as oxidative stress, with increased generation of free oxygen radicals and nitric oxide. In the absence of effective primary treatments, there is hope that interventions in muscle fibre apoptosis will bear promising therapeutic strategies.
Insights
Apoptotic cell death contributes to muscle fiber loss in neuromuscular disorders. Targeting apoptosis pathways offers potential therapeutic strategies for these conditions.
Area of Science:
- Cell Biology
- Molecular Biology
- Neuromuscular Disorders
Background:
- Apoptotic cell death mechanisms, alongside necrosis, are increasingly recognized as contributors to muscle fiber loss.
- This phenomenon is observed in various neuromuscular conditions, including muscular dystrophies, metabolic myopathies, and denervation injuries.
Purpose of the Study:
- To elucidate the role of apoptosis in muscle fiber loss in neuromuscular disorders.
- To identify key molecular effectors and triggers of apoptosis in affected muscle fibers.
- To explore the therapeutic potential of targeting apoptosis in these conditions.
Main Methods:
- Analysis of gene expression, specifically focusing on members of the bcl-2 family (e.g., bax, bcl-2).
- Investigation of mitochondrial membrane permeability transition pores and caspase activation.
- Morphological and biochemical assessment of apoptotic features, including DNA fragmentation.
Main Results:
- Up-regulation of bax and bcl-2 suggests their involvement in apoptotic pathways.
- Mitochondrial permeability transition and caspase activation are identified as key effectors.
- Apoptotic degradation of nuclei and contractile elements leads to localized muscle fiber atrophy and loss.
Conclusions:
- Apoptosis is a significant mechanism underlying muscle fiber loss in neuromuscular disorders.
- Homeostatic dysregulation and oxidative stress, including free radicals and nitric oxide, are identified as essential triggers.
- Interventions targeting muscle fiber apoptosis present promising therapeutic avenues in the absence of effective primary treatments.
Related Concept Videos
Cross-bridge Cycle
Satellite Stem Cells and Muscular Dystrophy
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis ll: Pathophysiology

